CEFTRIAXONE SODIUM

CEFTRIAXONE SODIUM was reported 38983 times

CEFTRIAXONE SODIUM is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PSEUDOCHOLELITHIASIS 103 0.9626
1 APPENDICOLITH 317 0.8191
2 ANTACID THERAPY 102 0.7846
3 SLEEP DISORDER THERAPY 141 0.7121
4 ANALGESIC THERAPY 164 0.5109
5 DRUG THERAPY 163 0.4808
6 ANTICOAGULANT THERAPY 99 0.3486
7 FACTOR V INHIBITION 67 0.3454
8 MALIGNANT MELANOMA STAGE 0 71 0.3397
9 CONGENITAL HIATUS HERNIA 74 0.3246
10 JARISCH-HERXHEIMER REACTION 168 0.2360
11 POSTRENAL FAILURE 95 0.2159
12 ACQUIRED FACTOR V DEFICIENCY 22 0.2000
13 BACTEROIDES INFECTION 52 0.1992
14 CLOSTRIDIUM TEST POSITIVE 273 0.1237
15 PULMONARY FUNCTION TEST ABNORMAL 181 0.1161
16 DISSEMINATED STRONGYLOIDIASIS 25 0.1142
17 RENAL PAPILLARY NECROSIS 24 0.1116
18 HYPERPHOSPHATAEMIA 206 0.0957
19 MICROSPORIDIA INFECTION 32 0.0912
20 PLEOCYTOSIS 50 0.0859
21 VITAMIN K DEFICIENCY 34 0.0846
22 BLOOD PHOSPHORUS INCREASED 229 0.0838
23 VANCOMYCIN INFUSION REACTION 30 0.0796
24 TRICHOSPORON INFECTION 32 0.0790
25 PNEUMOCOCCAL INFECTION 46 0.0777
26 DISSEMINATED ASPERGILLOSIS 35 0.0742
27 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 68 0.0734
28 CHEST X-RAY ABNORMAL 220 0.0717
29 CALCULUS URETERIC 50 0.0691
30 DISSEMINATED MUCORMYCOSIS 27 0.0685
31 INTENSIVE CARE UNIT ACQUIRED WEAKNESS 25 0.0658
32 CHOREOATHETOSIS 43 0.0633
33 GENERALISED BULLOUS FIXED DRUG ERUPTION 23 0.0618
34 KOUNIS SYNDROME 136 0.0598
35 EAR PRURITUS 204 0.0581
36 CORYNEBACTERIUM INFECTION 31 0.0579
37 BREATH SOUNDS ABNORMAL 271 0.0549
38 BLOOD GASES ABNORMAL 29 0.0538
39 ABDOMINAL COMPARTMENT SYNDROME 33 0.0518
40 INFECTIVE ANEURYSM 25 0.0505
41 PROPOFOL INFUSION SYNDROME 35 0.0496
42 DISSEMINATED CRYPTOCOCCOSIS 37 0.0489
43 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 370 0.0476
44 ACINETOBACTER INFECTION 52 0.0475
45 BLOOD LACTIC ACID INCREASED 248 0.0470
46 CRYSTALLURIA 25 0.0460
47 BRAIN ABSCESS 115 0.0454
48 PSEUDOMEMBRANOUS COLITIS 100 0.0447
49 NOCARDIOSIS 111 0.0434
50 PNEUMONIA NECROTISING 28 0.0433
51 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 1105 0.0429
52 THERAPEUTIC PRODUCT CROSS-REACTIVITY 38 0.0426
53 RHINITIS ALLERGIC 189 0.0424
54 STENOTROPHOMONAS INFECTION 57 0.0420
55 TOTAL LUNG CAPACITY DECREASED 67 0.0419
56 SYMMETRICAL DRUG-RELATED INTERTRIGINOUS AND FLEXURAL EXANTHEMA 34 0.0414
57 PULMONARY NOCARDIOSIS 33 0.0400
58 LINEAR IGA DISEASE 65 0.0390
59 ENDOCARDITIS BACTERIAL 30 0.0381
60 EOSINOPHILIC PNEUMONIA ACUTE 33 0.0381
61 FUNGAEMIA 60 0.0381
62 TOXIC ENCEPHALOPATHY 190 0.0375
63 APPENDICITIS 350 0.0374
64 NASAL POLYPS 180 0.0365
65 STRONGYLOIDIASIS 59 0.0365
66 SPUTUM PURULENT 24 0.0365
67 IRON DEFICIENCY 163 0.0362
68 EOSINOPHILIA 625 0.0356
69 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 179 0.0353
70 PNEUMOCYSTIS JIROVECII INFECTION 42 0.0351
71 BLOOD URIC ACID INCREASED 203 0.0351
72 ENTEROBACTER INFECTION 59 0.0351
73 ACQUIRED HAEMOPHILIA 35 0.0349
74 LUNG OPACITY 92 0.0349
75 VANISHING BILE DUCT SYNDROME 38 0.0341
76 FOETAL HEART RATE DECELERATION ABNORMALITY 24 0.0340
77 PNEUMONIA MYCOPLASMAL 27 0.0339
78 MUCORMYCOSIS 88 0.0338
79 TOXIC EPIDERMAL NECROLYSIS 502 0.0330
80 ALVEOLITIS 46 0.0326
81 VENTRICULAR FIBRILLATION 357 0.0321
82 MULTIPLE ORGAN DYSFUNCTION SYNDROME 895 0.0316
83 HYPOPHOSPHATAEMIA 233 0.0315
84 MENINGITIS BACTERIAL 45 0.0314
85 TRACHEOBRONCHITIS 24 0.0312
86 RED MAN SYNDROME 27 0.0307
87 SEPTIC EMBOLUS 25 0.0300
88 CARDIOGENIC SHOCK 423 0.0295
89 MYASTHENIA GRAVIS 237 0.0293
90 KLEBSIELLA INFECTION 147 0.0290
91 PROCALCITONIN INCREASED 34 0.0290
92 CSF PROTEIN INCREASED 24 0.0290
93 CLOSTRIDIUM DIFFICILE COLITIS 306 0.0288
94 FIXED ERUPTION 49 0.0285
95 MYASTHENIA GRAVIS CRISIS 42 0.0283
96 LISTERIOSIS 31 0.0280
97 BRONCHOPULMONARY ASPERGILLOSIS 217 0.0280
98 AORTIC STENOSIS 97 0.0278
99 PYURIA 27 0.0273
100 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 136 0.0273
101 INTERVERTEBRAL DISCITIS 51 0.0270
102 ENTEROCOCCAL INFECTION 130 0.0269
103 LONG QT SYNDROME 64 0.0267
104 PNEUMONIA STREPTOCOCCAL 29 0.0265
105 PULMONARY CAVITATION 23 0.0264
106 PLEURITIC PAIN 73 0.0264
107 FULL BLOOD COUNT ABNORMAL 276 0.0261
108 PNEUMONIA CRYPTOCOCCAL 24 0.0254
109 CRYPTOCOCCOSIS 41 0.0251
110 HAEMOLYTIC ANAEMIA 220 0.0245
111 RASH MORBILLIFORM 68 0.0245
112 AUTOIMMUNE HAEMOLYTIC ANAEMIA 84 0.0245
113 RASH MACULO-PAPULAR 540 0.0242
114 URETERIC OBSTRUCTION 33 0.0242
115 SYSTEMIC CANDIDA 59 0.0235
116 APGAR SCORE LOW 30 0.0233
117 MULTIPLE-DRUG RESISTANCE 72 0.0232
118 HYPOFIBRINOGENAEMIA 23 0.0232
119 CEREBRAL PALSY 22 0.0231
120 UPPER-AIRWAY COUGH SYNDROME 188 0.0228
121 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 73 0.0225
122 PATHOGEN RESISTANCE 203 0.0222
123 TROPONIN INCREASED 167 0.0219
124 CALCULUS URINARY 33 0.0214
125 AGRANULOCYTOSIS 394 0.0212
126 VASCULITIS 245 0.0210
127 MIXED LIVER INJURY 63 0.0209
128 DEVICE RELATED SEPSIS 42 0.0208
129 BRONCHIAL OBSTRUCTION 29 0.0206
130 SECONDARY IMMUNODEFICIENCY 25 0.0206
131 NEPHRITIS INTERSTITIAL 26 0.0206
132 ENCEPHALITIS AUTOIMMUNE 27 0.0205
133 HISTIOCYTOSIS HAEMATOPHAGIC 61 0.0205
134 TYPE IV HYPERSENSITIVITY REACTION 56 0.0204
135 CHOLESTATIC LIVER INJURY 45 0.0202
136 EMPYEMA 40 0.0201
137 RESPIRATORY SYMPTOM 57 0.0200
138 LUNG ABSCESS 42 0.0200
139 LOW BIRTH WEIGHT BABY 159 0.0200
140 ACUTE RESPIRATORY DISTRESS SYNDROME 352 0.0199
141 TORSADE DE POINTES 156 0.0199
142 HYDRONEPHROSIS 148 0.0197
143 PNEUMONIA STAPHYLOCOCCAL 39 0.0197
144 HAEMODYNAMIC INSTABILITY 149 0.0195
145 HYPERTRANSAMINASAEMIA 135 0.0194
146 ENDOCARDITIS 99 0.0193
147 HEPATITIS CHOLESTATIC 116 0.0192
148 STATUS EPILEPTICUS 216 0.0191
149 CLOSTRIDIUM COLITIS 23 0.0189
150 LUNG CONSOLIDATION 53 0.0189
151 BRAIN HERNIATION 56 0.0187
152 HYPERLACTACIDAEMIA 50 0.0186
153 BACTERIAL INFECTION 347 0.0186
154 CHOLESTASIS 356 0.0185
155 HEPATOSPLENOMEGALY 47 0.0183
156 ISCHAEMIC HEPATITIS 25 0.0182
157 PNEUMONIA PNEUMOCOCCAL 27 0.0182
158 HAEMOLYSIS 139 0.0180
159 PLATELET COUNT INCREASED 234 0.0179
160 ENCEPHALITIS 124 0.0179
161 CEREBELLAR SYNDROME 39 0.0178
162 NOSOCOMIAL INFECTION 39 0.0177
163 HEPATITIS TOXIC 46 0.0176
164 ASPERGILLUS INFECTION 114 0.0174
165 PYELONEPHRITIS ACUTE 34 0.0173
166 TUBULOINTERSTITIAL NEPHRITIS 324 0.0173
167 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 66 0.0173
168 DERMATITIS EXFOLIATIVE GENERALISED 60 0.0172
169 PNEUMOMEDIASTINUM 31 0.0171
170 QUADRIPARESIS 28 0.0169
171 LEUKOCYTOSIS 304 0.0168
172 VASCULAR DEVICE INFECTION 76 0.0167
173 SEPTIC SHOCK 725 0.0166
174 RENAL TUBULAR NECROSIS 163 0.0166
175 RESPIRATORY ALKALOSIS 27 0.0166
176 MENINGITIS CRYPTOCOCCAL 29 0.0166
177 INFLAMMATORY MARKER INCREASED 82 0.0165
178 PULSELESS ELECTRICAL ACTIVITY 69 0.0165
179 BENIGN PROSTATIC HYPERPLASIA 85 0.0164
180 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 38 0.0163
181 NORMOCYTIC ANAEMIA 24 0.0163
182 HEPATOCELLULAR INJURY 230 0.0162
183 HEPATITIS FULMINANT 48 0.0162
184 ACUTE RESPIRATORY FAILURE 306 0.0159
185 COMA SCALE ABNORMAL 46 0.0159
186 ASCITES 466 0.0158
187 RETROPERITONEAL HAEMATOMA 35 0.0158
188 HEPATIC CYTOLYSIS 201 0.0157
189 OTOTOXICITY 29 0.0157
190 TACHYPNOEA 213 0.0157
191 CLOSTRIDIUM DIFFICILE INFECTION 340 0.0156
192 STEVENS-JOHNSON SYNDROME 345 0.0155
193 OLIGURIA 96 0.0154
194 MEGACOLON 24 0.0153
195 DRUG-INDUCED LIVER INJURY 479 0.0153
196 BACTERAEMIA 180 0.0152
197 COVID-19 PNEUMONIA 179 0.0151
198 HISTOPLASMOSIS DISSEMINATED 24 0.0151
199 INFECTIOUS PLEURAL EFFUSION 23 0.0151
200 EOSINOPHILIC PNEUMONIA 47 0.0149
201 DISSEMINATED INTRAVASCULAR COAGULATION 210 0.0149
202 HYPERNATRAEMIA 74 0.0148
203 BICYTOPENIA 29 0.0148
204 CLOSTRIDIAL INFECTION 50 0.0148
205 ANURIA 126 0.0146
206 PNEUMONIA BACTERIAL 132 0.0144
207 ENCEPHALOPATHY 349 0.0142
208 PNEUMONIA KLEBSIELLA 26 0.0141
209 ESCHERICHIA INFECTION 116 0.0141
210 STAPHYLOCOCCAL BACTERAEMIA 61 0.0140
211 PREMATURE DELIVERY 223 0.0140
212 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 105 0.0140
213 RESPIRATORY ACIDOSIS 55 0.0140
214 HYPOVOLAEMIC SHOCK 67 0.0140
215 TRANSAMINASES INCREASED 311 0.0140
216 ORAL PRURITUS 32 0.0139
217 BRAIN DEATH 43 0.0139
218 ELECTROCARDIOGRAM QT PROLONGED 494 0.0137
219 FOETAL DISTRESS SYNDROME 29 0.0137
220 IMMUNE THROMBOCYTOPENIA 61 0.0133
221 DIABETES INSIPIDUS 32 0.0133
222 CHOLECYSTITIS ACUTE 75 0.0132
223 BLOOD CALCIUM INCREASED 116 0.0132
224 FIBRIN D DIMER INCREASED 47 0.0132
225 HYPOXIA 463 0.0131
226 CHOLANGITIS 81 0.0131
227 OTITIS MEDIA 43 0.0130
228 FOETAL GROWTH RESTRICTION 79 0.0130
229 PARTIAL SEIZURES 68 0.0130
230 HYPERCAPNIA 39 0.0129
231 PYELONEPHRITIS 112 0.0129
232 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 34 0.0128
233 ARTHRITIS BACTERIAL 52 0.0127
234 PULSE ABSENT 60 0.0126
235 PURPURA 111 0.0125
236 ANAPHYLACTIC SHOCK 323 0.0125
237 TOXIC SKIN ERUPTION 126 0.0125
238 MENINGITIS ASEPTIC 56 0.0125
239 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 213 0.0124
240 END STAGE RENAL DISEASE 226 0.0124
241 NEPHRITIS 41 0.0123
242 ACUTE KIDNEY INJURY 1871 0.0122
243 DERMATITIS EXFOLIATIVE 61 0.0122
244 NEUTROPHILIA 69 0.0121
245 ACUTE PULMONARY OEDEMA 68 0.0121
246 RESPIRATORY FAILURE 882 0.0121
247 SHOCK HAEMORRHAGIC 98 0.0120
248 LIVER ABSCESS 39 0.0120
249 DERMATITIS BULLOUS 87 0.0120
250 HEPATITIS 304 0.0119
251 DRUG RESISTANCE 305 0.0119
252 STAPHYLOCOCCUS TEST POSITIVE 25 0.0118
253 ESCHERICHIA SEPSIS 34 0.0117
254 CHOLANGITIS SCLEROSING 24 0.0117
255 BILE DUCT STONE 37 0.0116
256 GENE MUTATION 23 0.0116
257 NEPHROPATHY TOXIC 130 0.0116
258 HYPERLIPIDAEMIA 138 0.0115
259 RALES 67 0.0115
260 FEBRILE BONE MARROW APLASIA 49 0.0115
261 CHOLELITHIASIS 377 0.0115
262 ARTERIOSPASM CORONARY 46 0.0115
263 ENDOTRACHEAL INTUBATION 32 0.0114
264 HEPATIC NECROSIS 43 0.0114
265 HYPONATRAEMIA 642 0.0114
266 HEPARIN-INDUCED THROMBOCYTOPENIA 56 0.0114
267 CANDIDA INFECTION 191 0.0113
268 NEUROTOXICITY 198 0.0113
269 ABDOMINAL WALL HAEMATOMA 22 0.0113
270 HYPERTHERMIA 85 0.0111
271 VARICELLA ZOSTER VIRUS INFECTION 23 0.0111
272 HEPATOMEGALY 109 0.0111
273 HEPATITIS ACUTE 72 0.0111
274 PREMATURE BABY 332 0.0110
275 BLOOD CULTURE POSITIVE 33 0.0110
276 HENOCH-SCHONLEIN PURPURA 24 0.0110
277 RETROPERITONEAL HAEMORRHAGE 27 0.0109
278 RESPIRATORY DISTRESS 301 0.0109
279 TYPE I HYPERSENSITIVITY 38 0.0108
280 SHOCK 247 0.0107
281 HYPOALBUMINAEMIA 83 0.0107
282 HYPERSENSITIVITY VASCULITIS 28 0.0107
283 FOETAL DEATH 55 0.0106
284 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 26 0.0105
285 MACULE 29 0.0104
286 NEUROLOGICAL DECOMPENSATION 24 0.0104
287 METABOLIC ENCEPHALOPATHY 31 0.0103
288 LYMPHADENITIS 25 0.0103
289 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 27 0.0103
290 INTRACRANIAL PRESSURE INCREASED 57 0.0102
291 MENINGITIS 68 0.0102
292 NEONATAL RESPIRATORY DISTRESS SYNDROME 36 0.0102
293 PNEUMOCYSTIS JIROVECII PNEUMONIA 102 0.0101
294 CYTOMEGALOVIRUS VIRAEMIA 45 0.0101
295 ANAPHYLACTIC REACTION 556 0.0101
296 ATELECTASIS 97 0.0100
297 SEPSIS 1118 0.0100
298 PANCREATITIS NECROTISING 23 0.0100
299 ERYTHEMA NODOSUM 35 0.0100
300 NEPHROGENIC ANAEMIA 46 0.0099
301 EUGLYCAEMIC DIABETIC KETOACIDOSIS 40 0.0097
302 NEURALGIA 233 0.0096
303 STRIDOR 28 0.0095
304 HYPERPYREXIA 40 0.0094
305 ULCER 150 0.0094
306 CREPITATIONS 28 0.0094
307 LUNG INFILTRATION 83 0.0094
308 ACUTE HEPATIC FAILURE 128 0.0094
309 SNEEZING 209 0.0093
310 MULTI-ORGAN FAILURE 161 0.0093
311 UNRESPONSIVE TO STIMULI 240 0.0093
312 ACIDOSIS 71 0.0093
313 FLANK PAIN 87 0.0093
314 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 508 0.0092
315 COAGULOPATHY 154 0.0092
316 LIVER FUNCTION TEST INCREASED 198 0.0092
317 PSEUDOMONAS INFECTION 79 0.0092
318 METABOLIC ACIDOSIS 294 0.0092
319 RENAL FAILURE ACUTE 389 0.0092
320 UROSEPSIS 84 0.0091
321 BLOOD POTASSIUM DECREASED 273 0.0091
322 SKIN NECROSIS 47 0.0091
323 SPLENOMEGALY 106 0.0090
324 SINUS BRADYCARDIA 87 0.0090
325 PRIAPISM 31 0.0090
326 PULMONARY ALVEOLAR HAEMORRHAGE 50 0.0089
327 STAPHYLOCOCCAL SEPSIS 44 0.0089
328 STREPTOCOCCAL INFECTION 49 0.0088
329 STRESS CARDIOMYOPATHY 51 0.0088
330 AZOTAEMIA 35 0.0088
331 DRUG ERUPTION 155 0.0087
332 CARDIOPULMONARY FAILURE 34 0.0087
333 ASPARTATE AMINOTRANSFERASE INCREASED 462 0.0087
334 URINE OUTPUT DECREASED 76 0.0087
335 PULMONARY TUBERCULOSIS 37 0.0087
336 NORMOCHROMIC NORMOCYTIC ANAEMIA 26 0.0086
337 OSTEOMYELITIS 156 0.0086
338 ELECTROENCEPHALOGRAM ABNORMAL 27 0.0085
339 BLOOD TEST ABNORMAL 120 0.0085
340 CUTANEOUS VASCULITIS 31 0.0085
341 NYSTAGMUS 45 0.0085
342 CHOLECYSTITIS 101 0.0085
343 GUILLAIN-BARRE SYNDROME 41 0.0085
344 CYANOSIS 132 0.0084
345 HYPOKALAEMIA 387 0.0084
346 CYTOMEGALOVIRUS INFECTION REACTIVATION 37 0.0084
347 LARGE INTESTINE PERFORATION 58 0.0083
348 ANTINUCLEAR ANTIBODY POSITIVE 27 0.0083
349 ASPIRATION 91 0.0083
350 HYPERBILIRUBINAEMIA 86 0.0083
351 HYPERURICAEMIA 34 0.0083
352 PETECHIAE 86 0.0082
353 ALTERED STATE OF CONSCIOUSNESS 178 0.0082
354 CARDIAC ARREST 676 0.0082
355 PNEUMONIA VIRAL 26 0.0081
356 ERYTHEMA MULTIFORME 76 0.0081
357 TONGUE OEDEMA 31 0.0081
358 RASH PUSTULAR 59 0.0081
359 NORMAL NEWBORN 44 0.0081
360 PANCYTOPENIA 450 0.0080
361 OESOPHAGEAL CANDIDIASIS 32 0.0080
362 LIP OEDEMA 34 0.0080
363 LIVER INJURY 197 0.0080
364 PROTHROMBIN TIME PROLONGED 48 0.0080
365 PLEURAL EFFUSION 486 0.0080
366 LYMPHOCYTE COUNT INCREASED 26 0.0080
367 BLOOD CREATININE INCREASED 518 0.0079
368 FOOD INTOLERANCE 29 0.0079
369 THROMBOTIC MICROANGIOPATHY 77 0.0079
370 BLOOD UREA INCREASED 132 0.0079
371 GOUT 141 0.0079
372 THROMBOCYTOPENIA 873 0.0078
373 INTERNATIONAL NORMALISED RATIO INCREASED 222 0.0078
374 SERUM FERRITIN INCREASED 41 0.0078
375 ALANINE AMINOTRANSFERASE INCREASED 474 0.0077
376 THROMBOPHLEBITIS 27 0.0077
377 PNEUMOTHORAX 122 0.0077
378 THYROIDITIS 23 0.0077
379 C-REACTIVE PROTEIN INCREASED 278 0.0076
380 MYOCLONUS 91 0.0076
381 HYPERCHOLESTEROLAEMIA 73 0.0076
382 PROSTATITIS 23 0.0076
383 HYPOMAGNESAEMIA 105 0.0075
384 HYDROCEPHALUS 41 0.0075
385 AORTIC VALVE INCOMPETENCE 32 0.0075
386 DUODENAL ULCER 53 0.0075
387 DUODENITIS 23 0.0075
388 BLOOD LACTATE DEHYDROGENASE INCREASED 118 0.0074
389 ORAL CANDIDIASIS 98 0.0074
390 FACE OEDEMA 125 0.0074
391 GAMMA-GLUTAMYLTRANSFERASE INCREASED 164 0.0074
392 LYMPHOPENIA 104 0.0073
393 DRUG INTERACTION 1164 0.0073
394 BLOOD ALBUMIN DECREASED 58 0.0073
395 STAPHYLOCOCCAL INFECTION 241 0.0073
396 MICTURITION URGENCY 83 0.0073
397 HAEMODIALYSIS 61 0.0073
398 ABDOMINAL TENDERNESS 36 0.0072
399 RASH VESICULAR 35 0.0072
400 BRAIN OEDEMA 91 0.0072
401 NECROSIS 40 0.0072
402 HYPERTRIGLYCERIDAEMIA 42 0.0072
403 OCULAR ICTERUS 31 0.0071
404 GENERALISED TONIC-CLONIC SEIZURE 118 0.0071
405 MENTAL STATUS CHANGES 198 0.0071
406 DYSPHEMIA 31 0.0071
407 BACTERIAL SEPSIS 23 0.0071
408 CATATONIA 37 0.0070
409 LEUKOENCEPHALOPATHY 26 0.0070
410 LEUKOPENIA 349 0.0070
411 ELECTROLYTE IMBALANCE 81 0.0070
412 GENERALISED OEDEMA 86 0.0069
413 HYPERKALAEMIA 243 0.0069
414 BLOOD ALKALINE PHOSPHATASE INCREASED 171 0.0069
415 RESPIRATORY RATE INCREASED 61 0.0069
416 OBSTRUCTIVE AIRWAYS DISORDER 76 0.0068
417 SINUS TACHYCARDIA 97 0.0068
418 CARDIAC FAILURE ACUTE 45 0.0067
419 RED CELL DISTRIBUTION WIDTH INCREASED 28 0.0067
420 APNOEA 52 0.0067
421 BRONCHIECTASIS 45 0.0067
422 HEPATIC ENCEPHALOPATHY 62 0.0066
423 WHEEZING 393 0.0066
424 HYPERREFLEXIA 23 0.0066
425 JAUNDICE 177 0.0066
426 THROMBOCYTOSIS 24 0.0065
427 NECROTISING FASCIITIS 23 0.0065
428 RHABDOMYOLYSIS 271 0.0065
429 PANCREATITIS ACUTE 146 0.0065
430 BONE MARROW FAILURE 132 0.0065
431 WOUND HAEMORRHAGE 24 0.0065
432 ATAXIA 77 0.0065
433 LACRIMATION INCREASED 196 0.0065
434 UPPER GASTROINTESTINAL HAEMORRHAGE 109 0.0065
435 MYOSITIS 58 0.0065
436 BRONCHOPNEUMONIA 22 0.0064
437 ESCHERICHIA URINARY TRACT INFECTION 27 0.0063
438 MALNUTRITION 71 0.0063
439 DRUG LEVEL BELOW THERAPEUTIC 35 0.0063
440 DRUG LEVEL ABOVE THERAPEUTIC 29 0.0063
441 BLOOD CREATINE INCREASED 28 0.0063
442 EXPOSURE DURING PREGNANCY 392 0.0063
443 VENTRICULAR TACHYCARDIA 104 0.0063
444 LUNG DISORDER 308 0.0063
445 ORGANISING PNEUMONIA 31 0.0062
446 DELIRIUM 217 0.0062
447 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 37 0.0062
448 HEPATOTOXICITY 139 0.0062
449 FOETAL EXPOSURE DURING PREGNANCY 507 0.0062
450 SPUTUM DISCOLOURED 59 0.0062
451 GENERAL PHYSICAL HEALTH DETERIORATION 715 0.0062
452 HEPATIC FUNCTION ABNORMAL 230 0.0062
453 EOSINOPHIL COUNT INCREASED 51 0.0061
454 PULMONARY TOXICITY 43 0.0061
455 PYREXIA 2099 0.0061
456 SUPRAVENTRICULAR TACHYCARDIA 58 0.0061
457 SEROTONIN SYNDROME 115 0.0060
458 APLASTIC ANAEMIA 31 0.0059
459 DRUG LEVEL INCREASED 98 0.0059
460 TUMOUR LYSIS SYNDROME 52 0.0059
461 NEUTROPENIA 803 0.0059
462 ABSCESS 94 0.0059
463 PULMONARY HAEMORRHAGE 46 0.0059
464 ISCHAEMIA 27 0.0059
465 HAEMOPTYSIS 162 0.0058
466 HEPATIC FAILURE 175 0.0058
467 TRICUSPID VALVE INCOMPETENCE 46 0.0058
468 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 302 0.0058
469 ATRIOVENTRICULAR BLOCK FIRST DEGREE 25 0.0058
470 HYPOCALCAEMIA 109 0.0058
471 SUSPECTED OFF LABEL USE 26 0.0057
472 BRONCHOSPASM 82 0.0057
473 LACTIC ACIDOSIS 186 0.0057
474 LIVE BIRTH 48 0.0057
475 NEUROLEPTIC MALIGNANT SYNDROME 68 0.0057
476 PNEUMONIA ASPIRATION 143 0.0057
477 EYE PRURITUS 191 0.0057
478 MYOCARDITIS 65 0.0057
479 HYPERVOLAEMIA 28 0.0057
480 ATRIAL FLUTTER 45 0.0056
481 TACHYCARDIA 501 0.0056
482 CEREBRAL ISCHAEMIA 29 0.0056
483 ANAL FISSURE 30 0.0056
484 MATERNAL EXPOSURE DURING PREGNANCY 498 0.0056
485 PERIORBITAL OEDEMA 29 0.0056
486 CYTOPENIA 68 0.0055
487 ECCHYMOSIS 38 0.0055
488 PERICARDIAL EFFUSION 128 0.0055
489 LEFT VENTRICULAR DYSFUNCTION 37 0.0055
490 CONDITION AGGRAVATED 1672 0.0055
491 CANDIDIASIS 22 0.0055
492 CARDIO-RESPIRATORY ARREST 229 0.0055
493 DEPRESSED LEVEL OF CONSCIOUSNESS 216 0.0055
494 PULMONARY EMBOLISM 518 0.0054
495 CORONAVIRUS INFECTION 36 0.0054
496 BRADYCARDIA 287 0.0054
497 ILEUS PARALYTIC 24 0.0054
498 CYTOMEGALOVIRUS INFECTION 89 0.0053
499 CIRCULATORY COLLAPSE 91 0.0053
500 OXYGEN SATURATION DECREASED 300 0.0053
501 PAPILLOEDEMA 24 0.0053
502 PULMONARY MASS 79 0.0053
503 FEBRILE NEUTROPENIA 351 0.0053
504 PNEUMONITIS 144 0.0053
505 RENAL IMPAIRMENT 444 0.0053
506 EPSTEIN-BARR VIRUS INFECTION 33 0.0053
507 GASTROENTERITIS 77 0.0053
508 CACHEXIA 27 0.0052
509 ANAEMIA 994 0.0052
510 DEVICE RELATED INFECTION 80 0.0052
511 ENTEROCOLITIS 30 0.0052
512 LIVER FUNCTION TEST ABNORMAL 150 0.0052
513 DECUBITUS ULCER 42 0.0051
514 ANGIOEDEMA 228 0.0051
515 BLOOD BILIRUBIN INCREASED 139 0.0051
516 RENAL FAILURE 683 0.0051
517 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 49 0.0051
518 ADRENAL INSUFFICIENCY 62 0.0051
519 LYMPHOCYTE COUNT DECREASED 90 0.0051
520 HYPOTENSION 1019 0.0051
521 POLYNEUROPATHY 60 0.0050
522 THERAPY NON-RESPONDER 225 0.0050
523 HYPERAMMONAEMIA 25 0.0050
524 CHEILITIS 27 0.0050
525 STILLBIRTH 24 0.0050
526 ARTHRITIS INFECTIVE 23 0.0050
527 HYPOVOLAEMIA 29 0.0050
528 PREMATURE LABOUR 28 0.0049
529 WHITE BLOOD CELL COUNT INCREASED 187 0.0049
530 HAEMATOMA 125 0.0048
531 LYMPHADENOPATHY 170 0.0048
532 ACUTE MYOCARDIAL INFARCTION 141 0.0048
533 MELAENA 105 0.0048
534 HYPOTHERMIA 48 0.0047
535 HAEMATURIA 162 0.0047
536 RASH ERYTHEMATOUS 225 0.0047
537 HAEMATOCRIT DECREASED 93 0.0047
538 HAEMORRHAGE INTRACRANIAL 70 0.0047
539 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 48 0.0047
540 POLYURIA 38 0.0046
541 CARDIAC TAMPONADE 22 0.0046
542 CARDIAC MURMUR 40 0.0046
543 BLOOD CREATINE PHOSPHOKINASE INCREASED 133 0.0046
544 LIPASE INCREASED 35 0.0046
545 EMPHYSEMA 46 0.0046
546 PLEURISY 27 0.0045
547 INTESTINAL ISCHAEMIA 25 0.0045
548 OFF LABEL USE 3974 0.0045
549 IMMUNOSUPPRESSION 40 0.0045
550 HYPERGLYCAEMIA 164 0.0045
551 ANAL ABSCESS 24 0.0044
552 BLOOD CHOLESTEROL INCREASED 205 0.0044
553 CEREBRAL HAEMORRHAGE 156 0.0044
554 PROCTALGIA 28 0.0044
555 ABDOMINAL DISTENSION 453 0.0043
556 ENDOPHTHALMITIS 26 0.0043
557 OROPHARYNGEAL DISCOMFORT 39 0.0043
558 METABOLIC DISORDER 25 0.0043
559 OESOPHAGITIS 47 0.0043
560 COLITIS 163 0.0043
561 NEPHROPATHY 40 0.0043
562 HYPOGAMMAGLOBULINAEMIA 28 0.0043
563 MITRAL VALVE INCOMPETENCE 48 0.0042
564 HALLUCINATION, VISUAL 89 0.0042
565 SKIN LESION 115 0.0042
566 ODYNOPHAGIA 25 0.0042
567 PNEUMONIA 1355 0.0042
568 MYOPATHY 36 0.0042
569 RENAL CYST 33 0.0042
570 HERPES SIMPLEX 27 0.0042
571 HYPOKINESIA 60 0.0041
572 IRON DEFICIENCY ANAEMIA 38 0.0041
573 EMBOLISM 34 0.0041
574 URTICARIA 684 0.0041
575 BODY TEMPERATURE INCREASED 83 0.0041
576 NEUTROPHIL COUNT DECREASED 165 0.0040
577 LIVER DISORDER 179 0.0040
578 SUBARACHNOID HAEMORRHAGE 41 0.0040
579 ABDOMINAL PAIN 936 0.0040
580 PRODUCT USE IN UNAPPROVED INDICATION 993 0.0040
581 FACIAL PARALYSIS 34 0.0040
582 RESPIRATORY DISORDER 119 0.0040
583 HEMIPARESIS 67 0.0040
584 CHRONIC KIDNEY DISEASE 298 0.0039
585 NEUTROPHIL COUNT INCREASED 40 0.0039
586 CARDIOMEGALY 48 0.0039
587 THROMBOSIS 313 0.0039
588 CAESAREAN SECTION 45 0.0039
589 VENTRICULAR EXTRASYSTOLES 40 0.0038
590 FLUID OVERLOAD 56 0.0038
591 PAPULE 27 0.0038
592 ASTHMA 432 0.0038
593 RHINORRHOEA 246 0.0038
594 NASAL CONGESTION 223 0.0038
595 PROTEINURIA 72 0.0038
596 NEUTROPENIC SEPSIS 27 0.0038
597 INTERSTITIAL LUNG DISEASE 183 0.0038
598 EYE INFLAMMATION 36 0.0038
599 HYPOGLYCAEMIA 183 0.0038
600 SUBDURAL HAEMATOMA 54 0.0038
601 CORONARY ARTERY DISEASE 114 0.0038
602 ENTERITIS 24 0.0037
603 NERVOUS SYSTEM DISORDER 117 0.0037
604 DIARRHOEA HAEMORRHAGIC 35 0.0037
605 APHTHOUS ULCER 29 0.0037
606 UPPER RESPIRATORY TRACT INFECTION 172 0.0037
607 COMA 177 0.0037
608 CHEST DISCOMFORT 379 0.0037
609 JOINT INJURY 79 0.0037
610 GLOMERULAR FILTRATION RATE DECREASED 45 0.0037
611 CYTOKINE RELEASE SYNDROME 73 0.0036
612 RASH GENERALISED 94 0.0036
613 ACUTE CORONARY SYNDROME 30 0.0036
614 HYPOTONIA 36 0.0036
615 PARAESTHESIA ORAL 52 0.0036
616 TREATMENT FAILURE 298 0.0036
617 PULMONARY OEDEMA 161 0.0036
618 DIABETES MELLITUS 274 0.0036
619 LOWER RESPIRATORY TRACT INFECTION 162 0.0036
620 SOPOR 47 0.0035
621 ORAL DISORDER 26 0.0035
622 URINARY RETENTION 118 0.0035
623 THERAPY PARTIAL RESPONDER 55 0.0035
624 HEPATIC CIRRHOSIS 66 0.0035
625 DERMATITIS ALLERGIC 44 0.0035
626 EPILEPSY 106 0.0035
627 REBOUND EFFECT 39 0.0034
628 AUTOIMMUNE HEPATITIS 24 0.0034
629 AGITATION 253 0.0034
630 MYOCARDIAL ISCHAEMIA 39 0.0034
631 COLITIS ISCHAEMIC 23 0.0034
632 HYPERCALCAEMIA 42 0.0034
633 RENAL INJURY 101 0.0034
634 CEREBRAL INFARCTION 83 0.0034
635 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 30 0.0034
636 ATRIAL FIBRILLATION 330 0.0034
637 PALLOR 92 0.0034
638 ECONOMIC PROBLEM 51 0.0034
639 OEDEMA PERIPHERAL 409 0.0034
640 RECALLED PRODUCT ADMINISTERED 32 0.0034
641 PULMONARY FIBROSIS 64 0.0033
642 RASH PRURITIC 179 0.0033
643 ILEUS 41 0.0033
644 PARALYSIS 47 0.0033
645 OEDEMA 178 0.0033
646 MOUTH HAEMORRHAGE 24 0.0033
647 EYELID OEDEMA 38 0.0033
648 DRY MOUTH 265 0.0033
649 GASTRIC ULCER 62 0.0033
650 DIFFUSE LARGE B-CELL LYMPHOMA 25 0.0032
651 DIALYSIS 46 0.0032
652 DYSARTHRIA 122 0.0032
653 CELLULITIS 163 0.0032
654 DRUG INTOLERANCE 311 0.0032
655 SLEEP DISORDER 227 0.0032
656 BRAIN INJURY 32 0.0032
657 MUSCULOSKELETAL CHEST PAIN 49 0.0032
658 CHROMATURIA 71 0.0031
659 BLOOD MAGNESIUM DECREASED 27 0.0031
660 SWELLING 291 0.0031
661 RHINITIS 25 0.0031
662 DEEP VEIN THROMBOSIS 201 0.0031
663 HEPATIC ENZYME INCREASED 210 0.0031
664 PULMONARY HYPERTENSION 64 0.0031
665 RESPIRATORY ARREST 84 0.0030
666 HAEMOGLOBIN DECREASED 312 0.0030
667 SECRETION DISCHARGE 38 0.0030
668 SKIN INFECTION 34 0.0030
669 RIB FRACTURE 62 0.0030
670 ANHEDONIA 79 0.0030
671 DISEASE PROGRESSION 355 0.0030
672 CARDIAC FAILURE 239 0.0030
673 PLATELET COUNT DECREASED 315 0.0030
674 NO THERAPEUTIC RESPONSE 36 0.0029
675 INTENTIONAL PRODUCT MISUSE 257 0.0029
676 INFUSION RELATED REACTION 194 0.0029
677 GRAND MAL CONVULSION 27 0.0029
678 URINARY TRACT INFECTION 498 0.0029
679 PRODUCTIVE COUGH 139 0.0029
680 DERMATITIS 61 0.0029
681 FUNGAL INFECTION 97 0.0029
682 ACUTE MYELOID LEUKAEMIA 45 0.0029
683 ARTERIOSCLEROSIS 27 0.0029
684 CONFUSIONAL STATE 462 0.0029
685 DYSPNOEA 1616 0.0029
686 HEPATIC STEATOSIS 53 0.0028
687 CARDIOVASCULAR DISORDER 72 0.0028
688 SEIZURE 327 0.0028
689 DISORIENTATION 112 0.0028
690 PANCREATITIS 149 0.0028
691 CHILLS 330 0.0028
692 GASTRITIS 74 0.0028
693 SALIVARY HYPERSECRETION 28 0.0028
694 DRUG INEFFECTIVE 3670 0.0028
695 RESPIRATORY DEPRESSION 34 0.0028
696 HEMIPLEGIA 23 0.0028
697 SKIN LACERATION 30 0.0028
698 BLOOD CALCIUM DECREASED 31 0.0028
699 PHARYNGITIS 34 0.0027
700 VOMITING 1287 0.0027
701 SKIN PLAQUE 23 0.0027
702 HAEMATEMESIS 68 0.0027
703 RASH PAPULAR 60 0.0027
704 SKIN ULCER 69 0.0027
705 COUGH 748 0.0027
706 APHASIA 80 0.0026
707 MYELOSUPPRESSION 95 0.0026
708 MYELODYSPLASTIC SYNDROME 38 0.0026
709 CENTRAL NERVOUS SYSTEM LESION 36 0.0026
710 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 76 0.0026
711 EXPIRED PRODUCT ADMINISTERED 86 0.0026
712 BLISTER 145 0.0026
713 DISEASE RECURRENCE 122 0.0026
714 CONSTIPATION 556 0.0025
715 RASH 1098 0.0025
716 PERITONITIS 52 0.0025
717 CARDIOMYOPATHY 37 0.0025
718 PULMONARY CONGESTION 33 0.0025
719 COLD SWEAT 44 0.0025
720 INTENTIONAL PRODUCT USE ISSUE 218 0.0025
721 RASH MACULAR 87 0.0025
722 ISCHAEMIC STROKE 44 0.0025
723 VITAMIN D DEFICIENCY 24 0.0025
724 JOINT DISLOCATION 26 0.0025
725 SOMNOLENCE 495 0.0025
726 COVID-19 429 0.0024
727 EJECTION FRACTION DECREASED 38 0.0024
728 DYSPHAGIA 232 0.0024
729 TENDON RUPTURE 30 0.0024
730 GASTROINTESTINAL HAEMORRHAGE 203 0.0024
731 DIPLOPIA 63 0.0024
732 SARS-COV-2 TEST POSITIVE 32 0.0024
733 HYPERTHYROIDISM 35 0.0024
734 ERYTHEMA 496 0.0024
735 MUCOSAL INFLAMMATION 63 0.0024
736 TRANSIENT ISCHAEMIC ATTACK 80 0.0024
737 DERMATITIS CONTACT 27 0.0024
738 PHOTOSENSITIVITY REACTION 39 0.0024
739 INFECTION 340 0.0023
740 GASTRIC HAEMORRHAGE 27 0.0023
741 PERIPHERAL COLDNESS 32 0.0023
742 NEPHROLITHIASIS 106 0.0023
743 BLOOD PRESSURE DECREASED 153 0.0023
744 PHOTOPHOBIA 43 0.0023
745 SMALL INTESTINAL OBSTRUCTION 28 0.0023
746 HYPERSENSITIVITY 422 0.0023
747 RESTLESSNESS 82 0.0022
748 INTESTINAL PERFORATION 25 0.0022
749 LETHARGY 128 0.0022
750 PRESYNCOPE 54 0.0022
751 SUDDEN DEATH 23 0.0022
752 DYSURIA 80 0.0022
753 RED BLOOD CELL SEDIMENTATION RATE INCREASED 24 0.0022
754 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 154 0.0022
755 DYSKINESIA 87 0.0021
756 CYSTITIS 68 0.0021
757 FISTULA 24 0.0021
758 OBESITY 34 0.0021
759 LIP SWELLING 71 0.0021
760 TOXICITY TO VARIOUS AGENTS 358 0.0021
761 PRODUCT PRESCRIBING ISSUE 46 0.0021
762 BLOOD COUNT ABNORMAL 32 0.0021
763 BLOOD POTASSIUM INCREASED 34 0.0021
764 SPEECH DISORDER 109 0.0021
765 MUSCULOSKELETAL STIFFNESS 182 0.0021
766 HYPOPHAGIA 53 0.0021
767 LUNG INFECTION 32 0.0021
768 COGNITIVE DISORDER 96 0.0021
769 MOUTH ULCERATION 43 0.0020
770 PRURITUS GENERALISED 44 0.0020
771 INFLAMMATION 105 0.0020
772 DEAFNESS 53 0.0020
773 WHITE BLOOD CELL COUNT DECREASED 218 0.0020
774 ARRHYTHMIA 95 0.0020
775 PLASMA CELL MYELOMA 78 0.0020
776 HAEMATOCHEZIA 110 0.0020
777 SKIN REACTION 28 0.0020
778 RESPIRATORY TRACT INFECTION 51 0.0020
779 SWELLING FACE 127 0.0019
780 HYPERTENSION 412 0.0019
781 EPISTAXIS 143 0.0019
782 BLOOD SODIUM DECREASED 36 0.0019
783 DEHYDRATION 252 0.0019
784 CONJUNCTIVITIS 35 0.0019
785 DYSPNOEA EXERTIONAL 71 0.0019
786 IMMUNODEFICIENCY 28 0.0019
787 CONVULSION 107 0.0019
788 BLOOD PRESSURE SYSTOLIC INCREASED 36 0.0018
789 EAR INFECTION 49 0.0018
790 PRURITUS 707 0.0018
791 LABORATORY TEST ABNORMAL 54 0.0018
792 METASTASES TO LIVER 32 0.0018
793 OSTEOPOROSIS 74 0.0018
794 BRONCHITIS 133 0.0018
795 INFUSION SITE PAIN 23 0.0018
796 DIARRHOEA 1151 0.0018
797 CHEST PAIN 329 0.0018
798 VIRAL INFECTION 59 0.0018
799 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 85 0.0018
800 MEDICATION ERROR 98 0.0018
801 TREMOR 292 0.0018
802 URINARY INCONTINENCE 52 0.0018
803 FAECES DISCOLOURED 38 0.0018
804 SYNCOPE 174 0.0017
805 MUSCLE TIGHTNESS 28 0.0017
806 RED BLOOD CELL COUNT DECREASED 49 0.0017
807 THROAT TIGHTNESS 46 0.0017
808 PERICARDITIS 28 0.0017
809 PULMONARY ARTERIAL HYPERTENSION 24 0.0017
810 STOMATITIS 100 0.0016
811 OSTEOPENIA 25 0.0016
812 ASTHENIA 611 0.0016
813 NAUSEA 1282 0.0016
814 HEART RATE INCREASED 159 0.0016
815 ORAL HERPES 31 0.0016
816 POOR QUALITY SLEEP 34 0.0016
817 GASTROOESOPHAGEAL REFLUX DISEASE 127 0.0016
818 SWOLLEN TONGUE 49 0.0016
819 RECTAL HAEMORRHAGE 67 0.0016
820 LIMB DISCOMFORT 48 0.0015
821 NEUROPATHY PERIPHERAL 147 0.0015
822 LOSS OF CONSCIOUSNESS 198 0.0015
823 ANGINA PECTORIS 44 0.0015
824 EXTRAPYRAMIDAL DISORDER 38 0.0015
825 GASTROINTESTINAL DISORDER 137 0.0015
826 BLOOD TRIGLYCERIDES INCREASED 27 0.0015
827 DIABETES MELLITUS INADEQUATE CONTROL 27 0.0015
828 CRYING 55 0.0015
829 HALLUCINATION, AUDITORY 24 0.0015
830 POST PROCEDURAL COMPLICATION 29 0.0015
831 HYPERHIDROSIS 194 0.0015
832 UPPER LIMB FRACTURE 30 0.0015
833 PHARYNGEAL OEDEMA 23 0.0015
834 SINUSITIS 153 0.0015
835 LYMPHOMA 23 0.0015
836 SKIN EXFOLIATION 125 0.0015
837 HEART RATE DECREASED 52 0.0015
838 METASTASES TO BONE 24 0.0015
839 DECREASED APPETITE 339 0.0015
840 MUSCULAR WEAKNESS 165 0.0015
841 PSYCHOMOTOR HYPERACTIVITY 24 0.0014
842 HAEMORRHAGE 148 0.0014
843 OSTEONECROSIS OF JAW 35 0.0014
844 MYALGIA 240 0.0014
845 DYSPHONIA 82 0.0014
846 IMPAIRED HEALING 46 0.0014
847 DYSTONIA 27 0.0014
848 ABNORMAL BEHAVIOUR 55 0.0014
849 ABDOMINAL PAIN LOWER 35 0.0014
850 TREATMENT NONCOMPLIANCE 75 0.0014
851 OSTEOARTHRITIS 58 0.0014
852 KIDNEY INFECTION 26 0.0013
853 CONTRAINDICATED PRODUCT ADMINISTERED 40 0.0013
854 NIGHT SWEATS 42 0.0013
855 PRODUCT PRESCRIBING ERROR 31 0.0013
856 HYPOTHYROIDISM 41 0.0013
857 FEEDING DISORDER 26 0.0013
858 ORAL PAIN 28 0.0012
859 DIABETIC KETOACIDOSIS 30 0.0012
860 ABORTION SPONTANEOUS 50 0.0012
861 RENAL DISORDER 58 0.0012
862 CARDIAC FAILURE CONGESTIVE 99 0.0012
863 DIVERTICULITIS 34 0.0012
864 SEDATION 32 0.0012
865 MALIGNANT NEOPLASM PROGRESSION 125 0.0012
866 FRACTURE 23 0.0012
867 COLITIS ULCERATIVE 53 0.0012
868 VERTIGO 72 0.0012
869 TINNITUS 54 0.0012
870 BLOOD PRESSURE INCREASED 179 0.0012
871 PRODUCT USE ISSUE 218 0.0012
872 TOOTH LOSS 24 0.0012
873 NO ADVERSE EVENT 209 0.0012
874 FLUSHING 117 0.0011
875 BLINDNESS 46 0.0011
876 OSTEONECROSIS 37 0.0011
877 OROPHARYNGEAL PAIN 104 0.0011
878 INTESTINAL OBSTRUCTION 42 0.0011
879 PARAESTHESIA 175 0.0011
880 BURNING SENSATION 77 0.0011
881 WEIGHT DECREASED 306 0.0011
882 INJURY 77 0.0011
883 THERAPY CESSATION 56 0.0011
884 MOVEMENT DISORDER 35 0.0011
885 HALLUCINATION 82 0.0011
886 SKIN DISORDER 36 0.0011
887 BACK PAIN 248 0.0011
888 HERPES ZOSTER 61 0.0011
889 THROAT IRRITATION 47 0.0010
890 PAIN IN JAW 29 0.0010
891 PSYCHOTIC DISORDER 30 0.0010
892 MENTAL DISORDER 44 0.0010
893 AGGRESSION 50 0.0010
894 LOCALISED INFECTION 24 0.0010
895 THERAPEUTIC RESPONSE DECREASED 60 0.0010
896 INFLUENZA 109 0.0010
897 ANXIETY 274 0.0010
898 OVERDOSE 207 0.0010
899 MENTAL IMPAIRMENT 23 0.0009
900 MALAISE 410 0.0009
901 WOUND 26 0.0009
902 FEAR 25 0.0009
903 BONE DENSITY DECREASED 29 0.0009
904 EMOTIONAL DISTRESS 111 0.0009
905 FEELING HOT 56 0.0009
906 ARTHRITIS 71 0.0009
907 ACCIDENTAL OVERDOSE 33 0.0009
908 ABDOMINAL PAIN UPPER 183 0.0009
909 EYE SWELLING 32 0.0009
910 ECZEMA 45 0.0009
911 PAIN 526 0.0009
912 HEADACHE 530 0.0008
913 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 151 0.0008
914 FALL 276 0.0008
915 NECK PAIN 46 0.0008
916 MOBILITY DECREASED 59 0.0008
917 DISTURBANCE IN ATTENTION 44 0.0008
918 CEREBROVASCULAR ACCIDENT 136 0.0008
919 BONE PAIN 47 0.0008
920 ARTHRALGIA 329 0.0008
921 FATIGUE 615 0.0008
922 SYSTEMIC LUPUS ERYTHEMATOSUS 28 0.0008
923 VISUAL ACUITY REDUCED 26 0.0008
924 MUSCULOSKELETAL PAIN 41 0.0008
925 DEATH 654 0.0008
926 MYOCARDIAL INFARCTION 131 0.0008
927 HYPOAESTHESIA 112 0.0007
928 HYPOACUSIS 32 0.0007
929 DRY EYE 37 0.0007
930 PERIPHERAL SWELLING 114 0.0007
931 SKIN DISCOLOURATION 34 0.0007
932 ADVERSE DRUG REACTION 66 0.0007
933 DRUG EFFECT INCOMPLETE 26 0.0007
934 DIZZINESS 357 0.0007
935 SUICIDE ATTEMPT 43 0.0007
936 FLUID RETENTION 36 0.0007
937 PAIN IN EXTREMITY 208 0.0007
938 UNEVALUABLE EVENT 53 0.0007
939 PALPITATIONS 82 0.0007
940 GAIT DISTURBANCE 133 0.0007
941 DISCOMFORT 42 0.0007
942 INCORRECT ROUTE OF DRUG ADMINISTRATION 24 0.0007
943 ILLNESS 69 0.0007
944 CARDIAC DISORDER 61 0.0007
945 PRODUCT DOSE OMISSION ISSUE 190 0.0006
946 AMNESIA 42 0.0006
947 VISION BLURRED 88 0.0006
948 IRRITABILITY 38 0.0006
949 ABDOMINAL DISCOMFORT 106 0.0006
950 THERAPEUTIC RESPONSE UNEXPECTED 28 0.0006
951 OCULAR HYPERAEMIA 29 0.0006
952 WITHDRAWAL SYNDROME 25 0.0006
953 DYSPEPSIA 57 0.0006
954 NASOPHARYNGITIS 102 0.0006
955 DRUG WITHDRAWAL SYNDROME 47 0.0005
956 HOT FLUSH 39 0.0005
957 FLATULENCE 29 0.0005
958 DEPRESSED MOOD 27 0.0005
959 INFLUENZA LIKE ILLNESS 42 0.0005
960 MUSCLE SPASMS 92 0.0005
961 VISUAL IMPAIRMENT 61 0.0005
962 BALANCE DISORDER 42 0.0005
963 UNDERDOSE 35 0.0005
964 ARTHROPATHY 26 0.0005
965 INSOMNIA 124 0.0005
966 EYE PAIN 26 0.0005
967 INTENTIONAL OVERDOSE 29 0.0005
968 DEPRESSION 102 0.0004
969 WEIGHT INCREASED 100 0.0004
970 INCORRECT DOSE ADMINISTERED 101 0.0004
971 DRUG ABUSE 36 0.0004
972 BREAST CANCER 40 0.0004
973 BLOOD GLUCOSE INCREASED 80 0.0004
974 CATARACT 25 0.0004
975 MEMORY IMPAIRMENT 57 0.0004
976 ADVERSE EVENT 38 0.0004
977 CONTUSION 39 0.0004
978 MIGRAINE 38 0.0004
979 FEELING ABNORMAL 94 0.0004
980 DYSGEUSIA 29 0.0004
981 HOSPITALISATION 59 0.0004
982 THERAPY INTERRUPTED 27 0.0004
983 NEOPLASM MALIGNANT 23 0.0003
984 JOINT SWELLING 39 0.0003
985 ALOPECIA 60 0.0003
986 SUICIDAL IDEATION 24 0.0003
987 PSORIASIS 34 0.0003
988 PRODUCT QUALITY ISSUE 32 0.0002
989 RHEUMATOID ARTHRITIS 23 0.0002
990 INJECTION SITE PAIN 60 0.0002
991 DRY SKIN 26 0.0002
992 INJECTION SITE ERYTHEMA 23 0.0002
993 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 37 0.0002
994 DRUG DEPENDENCE 25 0.0002